Supplemental
Interest Paid
Regeneron Pharmaceuticals Interest Paid remained flat by 0.0% to $10.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 20.9%, from $13.15M to $10.40M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows a downward trend with a -7.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionSupplemental
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ4 2025Feb 4, 2026
How to read this metric
Increasing interest payments relative to debt levels may signal rising interest rates or a higher cost of borrowing.
Detailed definition
The total cash outflow for interest payments on debt obligations during the period. This metric highlights the cash cost...
Peer comparison
Used to compare the cost of debt and interest coverage ratios against industry peers.
Metric ID:
interest_paidHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $55.80M | $53.70M | $73.10M | $52.60M | $41.60M |
| YoY Change | — | -3.8% | +36.1% | -28.0% | -20.9% |
Range$41.60M – $73.10M
CAGR-7.1%
Avg YoY Growth-4.1%
Median YoY Growth-12.3%
Current Streak2 years decline
Interest Paid at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's interest paid?
- Regeneron Pharmaceuticals (REGN) reported interest paid of $10.40M in Q4 2025.
- How has Regeneron Pharmaceuticals's interest paid changed year-over-year?
- Regeneron Pharmaceuticals's interest paid decreased by 20.9% year-over-year, from $13.15M to $10.40M.
- What is the long-term trend for Regeneron Pharmaceuticals's interest paid?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's interest paid has grown at a -7.1% compound annual growth rate (CAGR), from $55.80M to $41.60M.
- What does interest paid mean?
- The total cash paid for interest on debt.